Corrigendum to “Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of Coptis chinensis Franchin Polycystic Ovary Syndrome”

In the article titled “Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of Coptis chinensis Franchin Polycystic Ovary Syndrome” [1], there are errors in the following sections that were introduced during the preparation of the manuscript.

In the Abstract section, “These results indicated that WZYZP has a protective effect on spermatogenesis disorder, suggesting that it could be an alternative choice for male infertility therapy” should be corrected to “These results indicated that Coptis chinensis has a therapeutic effect on polycystic ovary syndrome, suggesting that it could be an alternative choice for polycystic ovary syndrome.”

In Section 2.9, “WZYZP” should be corrected to “Coptis chinensis.”

In the legend of Figure 7, “WZYZP” should be corrected to “Coptis chinensis.”

The authors apologise for these errors and confirm that this does not affect the results or conclusions of the article.